ACTIVE

Laboratoires réunis

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result19,7 k €-92,0 %over 1 year
Revenue15,2 M €+1,0 %over 1 year
Equity4,2 M €+0,5 %over 1 year
Workforce83,4 ETP-3,6 %over 1 year

Identity

Source · BCE/KBO

Laboratoires réunis is a Private limited company incorporated in 1984. Its main activity is: Pre-primary education. Its registered office is in Fléron. It employs on average 83,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0427.701.407
Incorporation
07/12/1984
Legal form
Private limited company
Registered office
Rue Bureau 37
4621 Fléron · WallonieSee on map
Contributed capital
3 856 100,00 €
Latest accounts
31/12/2025
Average workforce
83,4 ETP
Joint committees (2)
  • 330
  • 33004
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 14 financial years

20252024202320222015
Income statement
Revenue15,2 M €15 M €15,4 M €17,1 M €–
EBITDA1,3 M €1,5 M €2,1 M €4 M €-450,1 k €
Operating result326,1 k €671,7 k €1 M €2,7 M €-475,7 k €
Net result19,7 k €247,1 k €537,5 k €1,7 M €-484,4 k €
Balance sheet
Equity4,2 M €4,1 M €3,9 M €3,9 M €-719,1 k €
Total assets7,7 M €8,7 M €9,4 M €11,7 M €1,2 M €
Cash559,5 k €686 k €1,4 M €2,4 M €105,3 k €
Debts3,6 M €4,5 M €5,5 M €7,8 M €1,9 M €
Other
Workforce83,4 ETP86,5 ETP93,2 ETP81,6 ETP30,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 19 ended

Active mandates

Fréderic DAUCHE

Director · since 24 juin 2024 · until 15 juillet 2028

Active
Isabelle EIMER

Director · since 15 juillet 2022 · until 15 juillet 2028

Active

Ended mandates

Stéphane EIMER

Director · since 10 décembre 2021 · until 22 juin 2022

Ended
Analyses de Biologie Clinique Dubois Emmanuel

Director · since 15 novembre 2019 · 0824.254.827

Represented by Emmanuel Dubois

Ended
Biologie Médicale Lebrun

Director · since 15 novembre 2019 · 0898.265.629

Represented by Lebrun John

Ended
BIOMOL

Director · since 15 novembre 2019 · 0887.780.127

Represented by Mollet Jean-Jacques

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202628/07/202516/07/202431/08/202315/09/202219/08/2021
General meeting29/05/202630/06/202511/07/202431/08/202322/08/202218/08/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202529/05/202630/06/2026FrenchPDF
Full model31/12/202430/06/202528/07/2025FrenchPDF
Full model31/12/202311/07/202416/07/2024FrenchPDF
Full model31/12/202231/08/202331/08/2023FrenchPDF
Full model31/12/202122/08/202215/09/2022FrenchPDF
Abridged model31/12/202018/08/202119/08/2021FrenchPDF
Abridged model31/12/201929/09/202028/10/2020FrenchPDF
Abridged model31/12/201828/08/201930/08/2019FrenchPDF
Abridged model31/12/201703/08/201828/08/2018FrenchPDF
Abridged model31/12/201628/08/201729/08/2017FrenchPDF
Abridged model31/12/201503/06/201629/08/2016FrenchPDF
Abridged model31/12/201405/06/201519/06/2015FrenchPDF
Abridged model31/12/201314/04/201406/05/2014FrenchPDF
Abridged model31/12/201207/06/201325/06/2013FrenchPDF
Abridged model31/12/201101/06/201226/06/2012FrenchPDF
Abridged model31/12/201003/06/201127/06/2011FrenchPDF
Abridged model31/12/200904/06/201009/07/2010FrenchPDF
Abridged model31/12/200805/06/200923/06/2009FrenchPDF
Abridged model31/12/200730/06/200816/09/2008FrenchPDF
Abridged model31/12/200601/06/200709/07/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 19 ended

Active mandates

Fréderic DAUCHE

Director · since 24 juin 2024 · until 15 juillet 2028

Active
Isabelle EIMER

Director · since 15 juillet 2022 · until 15 juillet 2028

Active

Ended mandates

Stéphane EIMER

Director · since 10 décembre 2021 · until 22 juin 2022

Ended
Analyses de Biologie Clinique Dubois Emmanuel

Director · since 15 novembre 2019 · 0824.254.827

Represented by Emmanuel Dubois

Ended
Biologie Médicale Lebrun

Director · since 15 novembre 2019 · 0898.265.629

Represented by Lebrun John

Ended
BIOMOL

Director · since 15 novembre 2019 · 0887.780.127

Represented by Mollet Jean-Jacques

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/08/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/08/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/08/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates04/01/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates30/12/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Restructuring23/06/2021
    CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring11/06/2021
    CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202519,7 k €↓
  2. 2024
    Annual accounts 2024247,1 k €↓
  3. 2023
    Annual accounts 2023537,5 k €↓
  4. 2022
    Annual accounts 20221,7 M €↑
  5. 2015
    Annual accounts 2015-484,4 k €↓
  6. 2014
    Annual accounts 201415,1 k €↑
  7. 2013
    Annual accounts 2013-6,2 k €↓
  8. 2012
    Annual accounts 201282,8 k €↑
  9. 2011
    Annual accounts 2011-34,4 k €↑
  10. 2010
    Annual accounts 2010-50,4 k €↓
  11. 2009
    Annual accounts 200924,2 k €↑
  12. 2008
    Annual accounts 2008-2,8 k €↓
  13. 2007
    Annual accounts 2007102,2 k €↑
  14. 2006
    Annual accounts 200619,1 k €
  15. 07/12/1984
    IncorporationPrivate limited company